Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0320938 METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS
The present invention generally relates to the detection, treatment or prevention of disease states. Specifically, the present invention relates to the...
2017/0320937 ANTI-INFLUENZA B VIRUS HEMAGGLUTININ ANTIBODIES AND METHODS OF USE
The present invention provides anti-influenza B virus hemagglutinin antibodies, compositions comprising anti-influenza B virus hemagglutinin antibodies, and...
2017/0320936 ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
The invention relates to the provision of antibody therapeutics and prophylactics that are tailored specifically for human use. The present invention provides...
2017/0320935 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
The invention provides a polypeptide containing at least one IgG Fc region, wherein said at least one IgG Fc region is glycosylated with at least one galactose...
2017/0320934 STABILIZED AND AUTONOMOUS ANTIBODY VH DOMAIN
The present invention relates to single domain antibodies comprising at least one modification relative to the 4D5 antibody scaffold or human germline VH3...
2017/0320933 CYTOKINE-BASED FUSION PROTEINS FOR TREATMENT OF IMMUNE DISORDERS
The present invention provides fusion proteins including an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine....
2017/0320932 ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR
A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The...
2017/0320931 METHODS OF PRODUCING A ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR
Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing...
2017/0320930 CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES
The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases...
2017/0320929 Fragments Of Syndecan-2 Having Anti-Angiogenic Activity
The present invention provides an anti-angiogenic peptide comprising an amino acid sequence having at least 70% identity to amino acid residues 123-140 of SEQ...
2017/0320928 ALPHA/BETA-POLYPEPTIDE ANALOGS OF GLUCAGON-LIKE PEPTIDE 1
Described herein are peptide analogs of glucagon-like peptide 1 (GLP-1) that retain agonist activity, but are more resistant to proteolytic degradation than...
2017/0320927 GLP-1 Derivatives and Uses Thereof
The invention relates to a derivative of a GLP-1 analogue of a general Formula I, which derivative comprises a side chain attached to a Lys residue at position...
2017/0320926 IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of...
2017/0320925 ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY
In certain aspects, the present invention provides compositions and methods for inducing utrophin expression in muscle with an ActRIIB protein as therapy for...
2017/0320924 FUNCTION SUPPRESSION TYPE OF GENETICALLY-MODIFIED RHODOCYTIN MUTANT
According to the present invention, a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, a pharmaceutical...
2017/0320923 PROTON-TRANSPORT VESICLE HAVING RECONSTITUTED HETEROLOGOUS PHOTOSENSITIVE PROTEINS AND METHOD FOR PREPARING SAME
The present invention relates to a proton-transport vesicle and a method for preparing the same, the proton-transfer vesicle comprising: (a) a single...
2017/0320922 MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES
The invention discloses a polypeptide with improved alkaline stability, which polypeptide comprises a mutant of a B or C domain of Staphylococcus Protein A...
2017/0320921 PROTEIN M RELATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES
The invention relates to a group of isolated polypeptides and derivatives that can bind genetically to immunoglobulins or antibodies. The invention also...
2017/0320920 ANTIGEN PEPTIDE COMPLEX FOR IMPROVED PRODUCTION OF ANTI-PEPTIDE ANTIBODIES
Anti-peptide antibodies (APAs) are extremely important tools for biomedical research. Many important techniques, such as immunoblots, ELISA immunoassays,...
2017/0320919 Modified Kappa Light Chain-Binding Polypeptides
The invention discloses kappa light chain-binding polypeptide comprising a mutated binding domain of Peptostreptococcus protein L, wherein at least one...
2017/0320918 RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOSITIONS THEREFROM
The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to...
2017/0320917 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
Protein kinase inhibitors and more specifically inhibitors of the protein kinase c-Jun amino terminal kinase are herein described. Additionally, JNK inhibitor...
2017/0320916 COMPLEXES OF CYTOMEGALOVIRUS PROTEINS
An isolated human cytomegalovirus (HCMV) membrane protein complex that comprises gH, gL and at least one more HCMV glycoprotein is provided. In some...
2017/0320915 LONG PEPTIDES OF 22-45 AMINO ACID RESIDUES THAT INDUCE AND/OR ENHANCE ANTIGEN SPECIFIC IMMUNE RESPONSES
Epitopes derived from human papilloma virus and peptides having a size of about 22-45 amino acid residues comprising minimal T cell epitopes are disclosed....
2017/0320914 MULTIVALENT LIGAND-LIPID CONSTRUCTS
Water dispersible, multivalent ligand-lipid constructs that spontaneously and stably incorporate into membranes are disclosed.
2017/0320913 IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of...
2017/0320912 PEPTIDES
The present invention relates to dual-site BACE1 inhibitors, their manufacture, pharmaceutical compositions containing them and their use as therapeutically...
2017/0320911 HIGH AFFINITY METAL-OXIDE BINDING PEPTIDES WITH REVERSIBLE BINDING
A dodecamer peptide, and its modified variant, having a repeating glycine-lysine sequence was created and formed to bind with high affinity to oxide surfaces...
2017/0320910 INHIBITORS FOR INHIBITING TUMOR METASTASIS
The present invention relates to chemical compounds that can in particular be used as structural mimetics of proline-rich peptides. The compounds of the...
2017/0320909 Purification of Biological Molecules
The present invention relates to improved processes and systems for purification of biological molecules, where the processes can be performed in a continuous...
2017/0320908 SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES
The present invention relates to cyclic amino acid molecules and methods of preparing the same, and in particular the macrocyclization of amino acids or linear...
2017/0320907 5.BETA.-6-ALKYL-7-HYDROXY-3-ONE STEROIDS AS INTERMEDIATES FOR THE PRODUCTION OF STEROIDAL FXR MODULATORS
The invention relates to compounds of formula (I): wherein R.sub.1, R.sub.2, Y, R.sub.4 and R.sub.5 are as defined herein. The compounds are intermediates in...
2017/0320906 COMPOUND FOR TREATING CLOSTRIDIUM DIFFICILE
The invention relates to compounds, compositions and polymers comprising a first component adapted to promote germination of Clostridium difficile (C.diff) and...
2017/0320905 METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID
Synthetic methods for preparing deoxycholic acid and intermediates thereof, high purity synthetic deoxycholic acid, compositions and methods of use are...
2017/0320904 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED
Precipitation promoters, which are an organic compound having one or more linear aliphatic hydrocarbon groups having not less than 10 carbon atoms, wherein the...
2017/0320902 PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS
Compositions and compounds having nucleoside phosphoramidites, and methods of making the same are provided. The compounds can also have one or more amino...
2017/0320901 Fluoride Trapping Arrangement
The present invention provides a new chemical process, a new cassette configuration, and new software for the automated production of multiple batches of an...
2017/0320900 PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING CRYSTALLINE ALPHA, ALPHA-TREHALOSE DI-HYDRATE
A process for enabling the production of a particulate composition containing crystalline trehalose dihydrate is provided. Including allowing an...
2017/0320899 HETEROCYCLIC COMPOUNDS AND USES THEREOF
Heterocyclic compounds of formula (I), methods for their preparation, pharmaceutical compositions containing such a compound and their therapeutic uses.
2017/0320898 Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery from...
Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function...
2017/0320897 USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES
The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a...
2017/0320896 PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES
Isocyanate-functional silanes are prepared in high yield by pyrolysis of an O-carbamate prepared by reaction of a dialkylcarbonate with an ...
2017/0320895 NEPRILYSIN INHIBITORS
In one aspect, the invention relates to compounds having the formula: ##STR00001## where R.sup.1-R.sup.6, a, b, and X are as defined in the specification, or a...
2017/0320894 MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI
The present invention concerns the compounds of formula ##STR00001## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically...
2017/0320893 NANNOCYSTIN PROCESS AND PRODUCTS
Described herein is a process for the total synthesis of macrolactones and macrolactams of formula I ##STR00001## including E- and Z-configuration thereof, in...
2017/0320892 Antimicrobial Compounds And Methods Of Making And Using The Same
The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for...
2017/0320891 7-(MORPHOLINYL)-2-(N-PIPERAZINYL) METHYL THIENO [2, 3-C] PYRIDINE DERIVATIVES AS ANTICANCER DRUGS
The present invention relates to novel series of substituted 7-(morpholinyl)-2-(N-piperazinyl)-methyl thieno [2, 3-c] pyridines of the following structure of...
2017/0320890 NOVEL 4-(ARYL)-N-(2-ALKOXYTHIENO[3,2-B]PYRAZIN-3-YL)-PIPERAZINE-1-CARBOXAM- IDE DERIVATIVE, AND...
The present invention relates to a novel 4-(aryl)-N-(2-alkoxythieno[3,2-b]pyrazin-3 -y)-piperazin-1-carboxamide derivative compound useful in the prevention or...
2017/0320889 HETEROCYCLIC DERIVATIVES AND USE THEREOF
A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the...
2017/0320888 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.